Literature DB >> 6122514

Hemodynamics, biochemical and reflexive changes produced by atenolol in hypertension.

G R Dreslinski, F H Messerli, F G Dunn, D H Suarez, E Reisin, E D Frohlich.   

Abstract

Hemodynamic (systemic and regional), metabolic and cardiovascular reflexive variables were measured before and after 4 weeks of beta blockade with atenolol in 10 patients with mild essential hypertension. Atenolol reduced mean arterial pressure, heart rate, cardiac index (all p less than 0.005) and renal vascular resistance (p less than 0.01) and increased total peripheral resistance (p less than 0.005). Glomerular filtration rate and renal blood flow were unchanged; plasma renin activity fell 43%. Reflexive cardioacceleration during the Valsalva maneuver and upright passive tilt was blunted. No changes were observed in circulating fluid volumes. In six patients followed for 1 year, blood pressure and heart rate were maintained at levels similar to those during the first 4 weeks. Atenolol was shown to be an effective oral antihypertensive that has no apparent deleterious hemodynamic effects on the renal and splanchnic circulations.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6122514     DOI: 10.1161/01.cir.65.7.1365

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

Review 1.  Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.

Authors:  A N Wadworth; D Murdoch; R N Brogden
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

2.  Correction of physiological alterations of hypertension.

Authors:  E D Frohlich
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

3.  Effect of acute administration of propranolol and atenolol on baroreflex function in normal man.

Authors:  A H Deering; D W Harron; J G Riddell; R G Shanks
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  Effects of nadolol and propranolol on renal function in hypertensive patients with moderately impaired renal function.

Authors:  K K Pun; C K Yeung; M K Chan
Journal:  Br J Clin Pharmacol       Date:  1985-10       Impact factor: 4.335

Review 5.  Role of vasodilation in the antihypertensive and antianginal effects of labetalol: implications for therapy of combined hypertension and angina.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1988-09       Impact factor: 3.727

6.  Cardiorenal Systems Modeling: Left Ventricular Hypertrophy and Differential Effects of Antihypertensive Therapies on Hypertrophy Regression.

Authors:  K Melissa Hallow; Charles H Van Brackle; Sommer Anjum; Sergey Ermakov
Journal:  Front Physiol       Date:  2021-06-16       Impact factor: 4.566

Review 7.  How Do Antihypertensive Drugs Work? Insights from Studies of the Renal Regulation of Arterial Blood Pressure.

Authors:  Holly Digne-Malcolm; Matthew C Frise; Keith L Dorrington
Journal:  Front Physiol       Date:  2016-07-29       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.